Hepatitis C (children and young people) - peginterferon alfa and ribavirin (TA300)
Peginterferon alfa with ribavirin is recommended as a possible treatment for children and young people with chronic hepatitis C.
What does this mean?
If your (or your child's) doctor thinks that peginterferon alfa with ribavirin is the right treatment, you (or your child) should be able to have the treatment on the NHS.
Peginterferon alfa with ribavirin should be available on the NHS within 3 months of the guidance being issued.
This guidance partially updates NICE TA106 Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C and NICE TA75 Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
This page was last updated: 27 November 2013
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.